Inscription Capital, LLC has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing lists 649 distinct positions held by the firm.
The report, signed by Compliance Ops, Sr. Consultant Nicole Goff, indicates that the firm held a total of 98,928,165 shares across the disclosed portfolio.
The filing details a broad range of holdings, including major technology and healthcare companies. Apple Inc. is listed as the largest position, with 32,600,376 shares. Other notable holdings include Amazon.com Inc. with 13,062,187 shares, and Alphabet Inc. Class C and Class A shares, which total 16,980,871 and 11,496,261 shares, respectively.
Healthcare and biotechnology companies are also represented, with positions in Eli Lilly & Co. (3,497,291 shares), Bristol-Myers Squibb Co. (286,834 shares), and Amgen Inc. (628,747 shares). Additionally, the filing includes a significant position in Archer Daniels Midland Co. with 256,874 shares.
The report lists the firm's principal office as 2925 Richmond Avenue Suite 425, Houston, TX 77098.
